Weesp, Netherlands

Paulus M Van Balken

This inventor holds 1 USPTO granted patent. Top assignee: Duphar International Research Bv. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paulus M Van Balken. Retrieved from https://idiyas.com/inventor/paulus-m-van-balken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paulus M Van Balken: Innovator in Oral Formulations

Introduction

Paulus M Van Balken is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral delayed immediate release formulations.

Latest Patents

Van Balken holds a patent for an "Oral delayed immediate release formulation and method for preparing the same." This innovation addresses the need for effective drug delivery systems that can optimize therapeutic outcomes.

Career Highlights

He is currently associated with Duphar International Research B.V., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has been instrumental in enhancing the efficacy of oral medications.

Collaborations

Some of his notable coworkers include Jules A C Elbers and Henderik W Frijlink, who have collaborated with him on various projects within the realm of pharmaceutical research.

Conclusion

Paulus M Van Balken's contributions to oral formulation technology exemplify the innovative spirit of modern pharmaceutical research. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…